Clinical trial
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After…
NCT00924638 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00924638 |
|---|---|
| Title | Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke |
| Official title | CRYptogenic STroke And underLying AF Trial |
| Acronym | CRYSTAL-AF |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cryptogenic Symptomatic Transient Ischemic Attack, Cryptogenic Ischemic Stroke |
| Intervention type | Device |
| Interventions | Reveal® XT Insertable Cardiac Monitor |
| Enrollment | 447 |
| Start date | Jun 1, 2009 |
| Primary completion | May 1, 2013 |
| Completion | May 1, 2013 |
| First posted | Jun 19, 2009 |
| Last update posted | Jul 28, 2014 |
| Countries | Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Slovakia, Spain and 2 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: